Xilio Therapeutics, Inc. (XLO)

NASDAQ: XLO · Real-Time Price · USD

8.28

-0.30 (-3.50%)

At close: May 22, 2026, 4:00 PM EDT

8.25

-0.03 (-0.36%)

After-hours: May 22, 2026, 4:10 PM EDT

Xilio Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	150.33	137.53	55.29	44.7	120.39	198.05
Cash & Short-Term Investments	150.33	137.53	55.29	44.7	120.39	198.05
Cash Growth	68.77%	148.74%	23.68%	-62.87%	-39.22%	929.49%
Other Current Assets	3.87	7.5	4.94	3.42	4.11	4.46
Total Current Assets	154.21	145.03	60.23	48.13	124.5	202.52
Net Property, Plant & Equipment	7.47	7.85	9.06	11.07	12.84	13.6
Other Long-Term Assets	1.81	1.81	1.78	1.73	1.83	1.95
Total Assets	163.49	154.69	71.08	60.93	139.17	218.06
Accounts Payable	1.06	3.17	2.57	1.05	3.13	3.14
Accrued Expenses	8.97	11.74	9.98	10.5	10.33	8.75
Current Portion of Long-Term Debt	-	-	-	3.32	6.67	0.08
Current Portion of Leases	1.38	1.34	1.19	1.05	0.92	0.8
Unearned Revenue	31.54	40.02	13.52	-	-	-
Other Current Liabilities	-	-	-	0.05	0.08	12.78
Total Current Liabilities	42.96	56.27	27.26	15.96	21.12	12.78
Long-Term Debt	-	-	-	-	3.17	9.63
Long-Term Leases	5.25	5.61	6.95	8.14	9.19	10.11
Other Long-Term Liabilities	42.73	57.53	19.26	-	0.05	0.12
Total Long-Term Liabilities	47.98	63.14	26.22	8.14	12.4	19.85
Total Liabilities	90.94	119.41	53.48	24.1	33.52	32.63
Common Stock	0	-	-	0	0	0
Additional Paid-in Capital	500.86	454.06	401.35	362.34	354.75	346.31
Retained Earnings	-428.32	-418.79	-383.75	-325.51	-249.11	-160.89
Total Common Shareholders' Equity	72.55	35.27	17.6	36.83	105.65	185.43
Shareholders' Equity	72.55	35.27	17.6	36.83	105.65	185.43
Total Liabilities & Equity	163.49	154.69	71.08	60.93	139.17	218.06
Total Debt	6.64	6.95	8.14	12.5	19.94	20.62
Net Cash (Debt)	143.7	130.58	47.15	32.2	100.45	177.44
Net Cash Growth	10.05%	176.94%	46.42%	-67.94%	-43.39%	-
Net Cash Per Share	12.40	15.62	12.34	16.39	51.34	443.09
Book Value	72.55	35.27	17.6	36.83	105.65	185.43
Book Value Per Share	6.26	4.22	4.60	18.75	54.00	463.05
Tangible Book Value	72.55	35.27	17.6	36.83	105.65	185.43
Tangible Book Value Per Share	6.26	4.22	4.60	18.75	54.00	463.05

Updated May 12, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q